Insider Transactions in Q2 2022 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Michael Ackermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,257
+0.35%
|
-
|
|
May 05
2022
|
Michael Ackermann Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$1,300,000
$13.5 P/Share
|
|
May 05
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,374
-0.22%
|
$64,488
$12.25 P/Share
|
|
May 04
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,738
-0.79%
|
$236,856
$12.67 P/Share
|
|
May 03
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
451,418
-15.33%
|
$5,868,434
$13.25 P/Share
|
|
May 02
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
41,800
-1.4%
|
$627,000
$15.19 P/Share
|